Global Allergy Diagnostics Market Report 2023: Featuring BioMerieux, Danaher, HOB Biotech, HYCOR Biomedical and Lincoln Diagnostics Among Others
08 mars 2023 04h08 HE
|
Research and Markets
Dublin, March 08, 2023 (GLOBE NEWSWIRE) -- The "Allergy Diagnostics Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists,...
Outlook on the Allergy Diagnostics Global Market to 2028: Increasing Levels of Environmental Pollution and Using Mobile Health to Diagnose Allergies Drives Growth
02 mars 2023 10h38 HE
|
Research and Markets
Dublin, March 02, 2023 (GLOBE NEWSWIRE) -- The "Global Allergy Diagnostics Market Size, Share & Industry Trends Analysis Report by End-user, Allergen, Test Type, Product & Services, Regional...
Insights on the Allergy Immunotherapies Global Market to 2028: Rising Awareness of Allergy Immunotherapies, Elevating Income Levels and Increasing Healthcare Expenditure Drives Growth
21 févr. 2023 13h18 HE
|
Research and Markets
Dublin, Feb. 21, 2023 (GLOBE NEWSWIRE) -- The "Allergy Immunotherapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
House Dust Mite Allergy Treatment Global Market Report 2022: Featuring Allergy Therapeutics, Bayer, GlaxoSmithKline, Johnson and Johnson & More
02 déc. 2022 08h23 HE
|
Research and Markets
Dublin, Dec. 02, 2022 (GLOBE NEWSWIRE) -- The "House Dust Mite Allergy Treatment Market By Treatment, By Type, By Route of administration, By Distribution channel: Global Opportunity Analysis and...
HpVac Appoints Joana Vitte, MD, PhD, as Chief Scientific Officer
23 nov. 2022 04h00 HE
|
AKAMPION
- Significant expansion of allergy research expertise Geneva, Switzerland, November 23, 2022 – HpVac SA, a company developing novel preventive and therapeutic first-line therapies against...
Intrommune Therapeutics Completes Enrollment in the Phase 1 OMEGA Study for Peanut Allergy
26 oct. 2022 09h35 HE
|
Intrommune Therapeutics
Observed only mild and transient adverse events, with no use of emergency epinephrine Observed 98.4% patient compliance to date with novel OMIT therapeutic modality Safely started patients on dose...
HpVac Announces New Animal Data of its Lead Compound Demonstrating Protection Against Allergic Asthma
18 oct. 2022 04h00 HE
|
AKAMPION
- Major milestone for accelerating the development of HpVac-13 in allergic diseases Geneva, Switzerland, October 18, 2022 – HpVac SA, a company developing novel preventive and therapeutic...
Allersearch® Laboratories Lands Savvy Cleaner's CEO Angela Brown as Brand Ambassador
17 août 2022 13h01 HE
|
Savvy Cleaner
CHARLOTTE, N.C., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Allersearch® Laboratories, the New Jersey-based company behind pet dander allergy relief for the last four decades, has a new message for pet...
Historic Bill Will Help Over 60 Million People with Asthma and Allergies
12 août 2022 17h35 HE
|
Asthma and Allergy Foundation of America
Washington, D.C., Aug. 12, 2022 (GLOBE NEWSWIRE) -- Today, Congress passed the Inflation Reduction Act. This bill makes significant investments to address the climate crisis and to improve access to...
AXIM Biotechnologies Celebrates Feature on the Vision is More Than 20/20™ Podcast
21 juil. 2022 09h00 HE
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, July 21, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting ocular...